Trial Profile
Pharmacokinetics and pharmacodynamics of Piperacillin-Tazobactam (PT) in pediatric oncology patients with fever and neutropenia.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 14 Mar 2018
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Fever; Neutropenia
- Focus Pharmacokinetics
- 10 Mar 2018 Status changed from recruiting to discontinued.
- 04 Aug 2017 New trial record